Alliancebernstein L.P. Adicet Bio, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.89 $4,218 - $7,182	-3,800 Reduced 9.37%	36,740 $69,000
Q2 2023 Aug 15, 2023	BUY	$2.13 - $7.13 $20,533 - $68,733	9,640 Added 31.2%	40,540 $98,000
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $24,839 - $41,535	4,500 Added 17.05%	30,900 $177,000
Q3 2022 Nov 15, 2022	BUY	$13.43 - $18.74 $181,305 - $252,989	13,500 Added 104.65%	26,400 $375,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $132,354 - $268,449	12,900 New	12,900 $188,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.